BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Methyldopa

An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.

297+ PubMed studies analyzed · 42 RCTs · Evidence Score: 47.4

Research Domains

Methyldopa has been studied across 18 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🌤️ Mood & Depression, 🫘 Kidney, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 56% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Methyldopa, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cisplatin
20 shared targets
Demeclocycline
17 shared targets
Levodopa
15 shared targets
Iodoacetamide
15 shared targets
myricetin-3-O-galactopyranoside
31 shared targets
Emodin
21 shared targets
Methysergide
16 shared targets
piceatannol
21 shared targets
tyrphostin
18 shared targets
darapladib
12 shared targets
Loading evidence profile...

This evidence profile for Methyldopa is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.